Michael Milyavsky

2.8k total citations
47 papers, 2.1k citations indexed

About

Michael Milyavsky is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Michael Milyavsky has authored 47 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 20 papers in Oncology and 9 papers in Hematology. Recurrent topics in Michael Milyavsky's work include DNA Repair Mechanisms (14 papers), Cancer-related Molecular Pathways (13 papers) and Epigenetics and DNA Methylation (7 papers). Michael Milyavsky is often cited by papers focused on DNA Repair Mechanisms (14 papers), Cancer-related Molecular Pathways (13 papers) and Epigenetics and DNA Methylation (7 papers). Michael Milyavsky collaborates with scholars based in Israel, Canada and United States. Michael Milyavsky's co-authors include Varda Rotter, Naomi Goldfinger, Neta Erez, Igor Shats, Xiaohu Tang, Irit Zurer, Ran Brosh, Doron Ginsberg, Eytan Domany and Ira Kogan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Michael Milyavsky

45 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Milyavsky Israel 23 1.5k 725 456 283 251 47 2.1k
Levi J. Beverly United States 28 1.7k 1.1× 601 0.8× 403 0.9× 110 0.4× 345 1.4× 65 2.7k
Mohit Trikha United States 29 1.2k 0.8× 930 1.3× 384 0.8× 142 0.5× 402 1.6× 55 2.5k
Frédérick A. Mallette Canada 24 1.8k 1.2× 598 0.8× 504 1.1× 681 2.4× 511 2.0× 39 2.7k
Alina Molchadsky Israel 21 1.3k 0.9× 797 1.1× 518 1.1× 112 0.4× 101 0.4× 28 1.8k
Frederic Tort Spain 19 2.6k 1.7× 1.3k 1.8× 550 1.2× 243 0.9× 219 0.9× 38 3.4k
Miriam Erlacher Germany 23 1.6k 1.1× 561 0.8× 266 0.6× 145 0.5× 641 2.6× 78 2.5k
Melanie Braig Germany 15 1.3k 0.8× 450 0.6× 197 0.4× 642 2.3× 258 1.0× 22 1.8k
Aleksandra Franovic United States 18 1.3k 0.8× 600 0.8× 744 1.6× 172 0.6× 200 0.8× 38 2.0k
Carla P. Martins United Kingdom 19 2.0k 1.3× 1.4k 2.0× 611 1.3× 281 1.0× 531 2.1× 25 3.1k
Naoharu Takano Japan 23 1.3k 0.9× 595 0.8× 978 2.1× 129 0.5× 348 1.4× 45 2.5k

Countries citing papers authored by Michael Milyavsky

Since Specialization
Citations

This map shows the geographic impact of Michael Milyavsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Milyavsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Milyavsky more than expected).

Fields of papers citing papers by Michael Milyavsky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Milyavsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Milyavsky. The network helps show where Michael Milyavsky may publish in the future.

Co-authorship network of co-authors of Michael Milyavsky

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Milyavsky. A scholar is included among the top collaborators of Michael Milyavsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Milyavsky. Michael Milyavsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zipin‐Roitman, Adi, Dror Tobi, Andrii Bazylevich, et al.. (2025). Novel dual action chimera doxorubizen demonstrates superior efficacy to doxorubicin in acute leukemia. Scientific Reports. 15(1). 10607–10607. 1 indexed citations
2.
Milyavsky, Michael, Shahar Dotan, Claudia Waskow, et al.. (2023). T Cells Expressing a Modified FcγRI Exert Antibody-Dependent Cytotoxicity and Overcome the Limitations of CAR T-cell Therapy against Solid Tumors. Cancer Immunology Research. 11(6). 792–809. 2 indexed citations
3.
Bercovich, Akhiad, Noa Chapal-Ilani, Amanda Mitchell, et al.. (2021). Recurrent deletions in clonal hematopoiesis are driven by microhomology-mediated end joining. Nature Communications. 12(1). 2455–2455. 20 indexed citations
4.
Yassin, Muhammad, Nour Ershaid, Adi Zipin‐Roitman, et al.. (2019). An ERG Enhancer–Based Reporter Identifies Leukemia Cells with Elevated Leukemogenic Potential Driven by ERG-USP9X Feed-Forward Regulation. Cancer Research. 79(15). 3862–3876. 6 indexed citations
5.
Yassin, Muhammad, Peter van Galen, B Bernstein, et al.. (2019). A novel method for detecting the cellular stemness state in normal and leukemic human hematopoietic cells can predict disease outcome and drug sensitivity. Leukemia. 33(8). 2061–2077. 10 indexed citations
6.
Milyavsky, Michael, Muhammad Yassin, Nour Ershaid, et al.. (2019). ERG ENHANCER-BASED REPORTER IDENTIFIES LEUKEMIA CELLS WITH ELEVATED LEUKEMOGENIC POTENTIAL DRIVEN BY ERG-USP9X FEED-FORWARD REGULATION. Experimental Hematology. 76. S78–S78.
7.
Beider, Katia, Hila Magen, Jonathan Canaani, et al.. (2019). The mTOR inhibitor everolimus overcomes CXCR4-mediated resistance to histone deacetylase inhibitor panobinostat through inhibition of p21 and mitotic regulators. Biochemical Pharmacology. 168. 412–428. 14 indexed citations
8.
Yassin, Muhammad, et al.. (2017). DNA-damage response in hematopoietic stem cells: an evolutionary trade-off between blood regeneration and leukemia suppression. Carcinogenesis. 38(4). 367–377. 34 indexed citations
9.
Milyavsky, Michael, et al.. (2013). Differences between human and rodent DNA-damage response in hematopoietic stem cells: at the crossroads of self-renewal, aging and leukemogenesis. Translational Cancer Research. 2(5). 372–383. 5 indexed citations
10.
Milyavsky, Michael, Olga I. Gan, Magan Trottier, et al.. (2010). A Distinctive DNA Damage Response in Human Hematopoietic Stem Cells Reveals an Apoptosis-Independent Role for p53 in Self-Renewal. Cell stem cell. 7(2). 186–197. 209 indexed citations
11.
Buganim, Yosef, Ido Goldstein, Doron Lipson, et al.. (2010). A Novel Translocation Breakpoint within the BPTF Gene Is Associated with a Pre-Malignant Phenotype. PLoS ONE. 5(3). e9657–e9657. 49 indexed citations
12.
Ornatsky, Olga, Robert Kinach, Michael Milyavsky, et al.. (2008). Element-tagged immunoassay with ICP-MS detection: Evaluation and comparison to conventional immunoassays. Journal of Immunological Methods. 336(1). 56–63. 52 indexed citations
13.
Milyavsky, Michael, Igor Shats, Ran Brosh, et al.. (2007). Inactivation of Myocardin and p16 during Malignant Transformation Contributes to a Differentiation Defect. Cancer Cell. 11(2). 133–146. 61 indexed citations
14.
Tang, Xinjing, Michael Milyavsky, Naomi Goldfinger, & Varda Rotter. (2007). Amyloid-β precursor-like protein APLP1 is a novel p53 transcriptional target gene that augments neuroblastoma cell death upon genotoxic stress. Oncogene. 26(52). 7302–7312. 27 indexed citations
15.
Buganim, Yosef, Eyal Kalo, Ran Brosh, et al.. (2006). Mutant p53 Protects Cells from 12- O -Tetradecanoylphorbol-13-Acetate–Induced Death by Attenuating Activating Transcription Factor 3 Induction. Cancer Research. 66(22). 10750–10759. 31 indexed citations
16.
Kogan, Ira, Naomi Goldfinger, Michael Milyavsky, et al.. (2006). hTERT-Immortalized Prostate Epithelial and Stromal-Derived Cells: an Authentic In vitro Model for Differentiation and Carcinogenesis. Cancer Research. 66(7). 3531–3540. 86 indexed citations
17.
Milyavsky, Michael, Yuval Tabach, Igor Shats, et al.. (2005). Transcriptional Programs following Genetic Alterations in p53 , INK4A , and H-Ras Genes along Defined Stages of Malignant Transformation. Cancer Research. 65(11). 4530–4543. 51 indexed citations
18.
Shats, Igor, Michael Milyavsky, Xiaohu Tang, et al.. (2004). p53-dependent Down-regulation of Telomerase Is Mediated by p21. Journal of Biological Chemistry. 279(49). 50976–50985. 119 indexed citations
19.
Milyavsky, Michael, Neta Erez, Devorah Matas, et al.. (2001). Structural and functional involvement of p53 in BER in vitro and in vivo. Oncogene. 20(5). 581–589. 60 indexed citations
20.
Milyavsky, Michael. (2001). Activation of p53 protein by telomeric (TTAGGG)n repeats. Nucleic Acids Research. 29(24). 5207–5215. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Levi J. Beverly Breakdown of academic impact, for papers by Mohit Trikha Breakdown of academic impact, for papers by Frédérick A. Mallette Breakdown of academic impact, for papers by Alina Molchadsky Breakdown of academic impact, for papers by Frederic Tort Breakdown of academic impact, for papers by Miriam Erlacher Breakdown of academic impact, for papers by Melanie Braig Breakdown of academic impact, for papers by Aleksandra Franovic Breakdown of academic impact, for papers by Carla P. Martins Breakdown of academic impact, for papers by Naoharu Takano
Rankless by CCL
2026